Edition:
India

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

90.56EUR
17 Nov 2017
Change (% chg)

€-0.24 (-0.26%)
Prev Close
€90.80
Open
€91.02
Day's High
€91.17
Day's Low
€90.56
Volume
471,356
Avg. Vol
563,628
52-wk High
€115.20
52-wk Low
€89.04

Select another date:

Mon, Nov 13 2017

BRIEF-Orexigen Therapeutics announces commercialization and distributorship agreement with Merck KGaA, Darmstadt

* Orexigen Therapeutics announces commercialization and distributorship agreement with Merck KGaA, Darmstadt, Germany for contrave in Latin America

Merck KGaA has contacted prospective buyers of consumer health

FRANKFURT Germany's Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction, even as a much larger rival business is about to come to market.

Merck KGaA has contacted prospective buyers of consumer health

FRANKFURT, Nov 9 Germany's Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction, even as a much larger rival business is about to come to market.

UPDATE 1-Merck KGaA tones down outlook but consumer health shines

* Sales, profit to hit lower end of target ranges on strong eur

CORRECTED-BRIEF-Merck KGaA, Samsung Biologics sign MoU on strategic alliance

* Says MilliporeSigma signs memorandum of understanding (MoU) with Samsung Biologics for strategic alliance on biopharma manufacturing, biologics process development‍​

BRIEF-Merck KGaA: Canadian patent office to grant patent application for CRISPR technology

* MERCK KGAA - CANADIAN PATENT OFFICE TO GRANT MERCK KGAA, DARMSTADT, GERMANY'S PATENT APPLICATION FOR CRISPR TECHNOLOGY

Police search Merck KGaA's French plant in thyroid pill inquiry

LYON, France French police searched German drugmaker Merck KGaA's plant in Lyon on Tuesday as part of an investigation into complaints by patients about changes to its thyroid drug Levothyrox, a company spokeswoman said.

REFILE-Police search Merck KGaA's French plant in thyroid pill inquiry

LYON, France, Oct 3 French police searched German drugmaker Merck KGaA's plant in Lyon on Tuesday as part of an investigation into complaints by patients about changes to its thyroid drug Levothyrox, a company spokeswoman said.

Merck KGaA eyes up to 700 million euro Mavenclad sales in EU

FRANKFURT Germany's Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments against the neurological disease, of up to 700 million euros ($823 million) in the European Union.

Merck KGaA CFO: 2017 profit guidance "damn challenging"

FRANKFURT, Sept 28 Germany's Merck KGaA said it expected to meet its 2017 guidance, but warned it wouldn't be easy due to headwinds from currency fluctuations and a tough liquid crystals business.

Select another date: